Adjuvant Treatment With Abatacept to Promote Remission During Peanut Oral Immunotherapy
Condition: Peanut Allergy Interventions: Drug: Abatacept; Other: Peanut oral immunotherapy Sponsors: Philippe Bégin; Centre hospitalier de l'Université de Montréal (CHUM) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 4, 2021 Category: Research Source Type: clinical trials
Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis
Conditions: Granulomatosis With Polyangiitis; Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Interventions: Drug: Rituximab; Drug: Tocilizumab; Drug: Abatacept Sponsors: Assistance Publique - Hôpitaux de Paris; URC/CIC (Clinical Research Unit) Paris Descartes Necker-Cochin Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 4, 2021 Category: Research Source Type: clinical trials
Adjuvant Treatment With Abatacept to Promote Remission During Peanut Oral Immunotherapy
Condition: Peanut Allergy Interventions: Drug: Abatacept; Other: Peanut oral immunotherapy Sponsors: Philippe Bégin; Centre hospitalier de l'Université de Montréal (CHUM) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 4, 2021 Category: Research Source Type: clinical trials
Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis
Conditions: Granulomatosis With Polyangiitis; Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Interventions: Drug: Rituximab; Drug: Tocilizumab; Drug: Abatacept Sponsors: Assistance Publique - Hôpitaux de Paris; URC/CIC (Clinical Research Unit) Paris Descartes Necker-Cochin Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 4, 2021 Category: Research Source Type: clinical trials
Adjuvant Treatment With Abatacept to Promote Remission During Peanut Oral Immunotherapy
Condition: Peanut Allergy Interventions: Drug: Abatacept; Other: Peanut oral immunotherapy Sponsors: Philippe Bégin; Centre hospitalier de l'Université de Montréal (CHUM) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 4, 2021 Category: Research Source Type: clinical trials
Abatacept s.c. for aGVHD Prevention in Haplo-HCT
Conditions: Abatacept; Acute-graft-versus-host Disease; Haplo-identical HCT; Prevention Interventions: Drug: Lower dose of abatacept; Drug: Higher dose of abatacept Sponsor: The First Affiliated Hospital of Soochow University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2020 Category: Research Source Type: clinical trials